Stock Information
Soleno Therapeutics Inc (SLNO)
Ticker Symbol: SLNO
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,728.38 mil
Piotroski score: 7
PE Ratio: 75.2248
EPS (TTM): 0.1615
Revenue (TTM): $3.20 M
Dividend Yield: N/A%
ROE: 5.9%
Latest News
-
Relmada Therapeutics: 2 New Assets, 2 New 'Blockbusters'? I'd Wait And See
Mon, Mar 30, 2026 3:16 PM
Key Financials
Financial data not available